Login / Signup

Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3.

M YunokawaN KuriharaN IshizukaH KanaoH KajiyamaM ShimadaA OkamotoD AokiT SugiyamaT Enomoto
Published in: Gynecologic oncology (2024)
The incidence of progression events for OCCC peaked at 12 months and most progression events occurred within 24 months. Close follow-up for the initial 24 months post-treatment and fewer visits thereafter may be acceptable. However, closely monitoring symptoms and examining patients based on differences in progression rates at different sites may be important.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • clear cell
  • chronic kidney disease
  • risk factors
  • study protocol
  • peritoneal dialysis
  • randomized controlled trial
  • patient reported outcomes